Pay to Marwadi

Company Profile

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE697.757.65 (+1.11 % )
PREV CLOSE (Rs.) 690.10
OPEN PRICE (Rs.) 702.00
BID PRICE (QTY) 697.65 (5 )
OFFER PRICE (QTY) 700.90 (5 )
VOLUME 8
TODAY'S LOW / HIGH (Rs.)697.75 702.00
52 WK LOW / HIGH (Rs.)597.95 977.45
NSE701.00 12.1 (+1.76 % )
PREV CLOSE(Rs.) 688.90
OPEN PRICE (Rs.) 689.90
BID PRICE (QTY) 698.85 (16 )
OFFER PRICE (QTY) 700.90 (10 )
VOLUME 2329
TODAY'S LOW / HIGH(Rs.) 689.05 702.20
52 WK LOW / HIGH (Rs.)598.6 978

Board Meetings

Source Date Board Meeting Date Details
01-Apr-2024 28-May-2024 Audited Results
16-Feb-2024 21-Feb-2024 Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023.
27-Dec-2023 02-Feb-2024 Quarterly Results
25-Oct-2023 08-Nov-2023 Quarterly Results (Revised)
18-Oct-2023 26-Oct-2023 Quarterly Results
06-Oct-2023 11-Oct-2023 Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alio, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alio, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. The Board, would further convene an Extra-ordinary General Meeting or postal ballot to obtain the approval of shareholders for the above proposal, once approved by the Board.
03-Oct-2023 05-Oct-2023 Inter alia, to consider and approve the Proposal for raising of funds by the Company
10-Jul-2023 07-Aug-2023 Quarterly Results (Revised)
07-Jul-2023 01-Aug-2023 Quarterly Results
03-May-2023 25-May-2023 Audited Results